Researchers have discovered and analyzed a rare but serious side effect of an innovative form of blood cancer therapy. The ...
Some forms of blood cancer, such as multiple myeloma and lymphoma, are malignant diseases that originate from immune cells, specifically lymphocytes ...
24 Although the benefit of CAR T-cell therapy for multiple myeloma continues to outweigh the risk, vigilant monitoring for T-cell lymphoma should be implemented. Supported by Johnson & Johnson and ...
During a Case-Based Roundtable® event, Muhammad Umair Mushtaq, MD, discussed managing long-term toxicity concerns related to ...